NASTAD Announces 2021-2022 Board of Directors

By Kyle Taylor June 2, 2021

FOR IMMEDIATE RELEASE: June 2, 2021

CONTACT: Kyle Taylor
Director, Communications, NASTAD
ktaylor@NASTAD.org

NASTAD Announces 2021-2022 Board of Directors

Washington, DC – Wednesday, May 26, NASTAD, a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S., announced its 2021-2022 Board of Directors. NASTAD is governed by a 23-member, elected Board charged with making policy and program decisions on behalf of the full membership.

The 2021-2022 Board of Directors includes:  

Officers (Executive Committee)
Marlene McNeese, Houston, Chair
Elizabeth Crutsinger-Perry, Washington, Chair-Elect
Ricardo Fernandez, Arizona, Vice Chair
Jeremy Turner, Indiana, Secretary-Treasurer
Johanne Morne, New York, Immediate Past-Chair (ex-officio, voting)
Stephen Lee, NASTAD Executive Director (ex-officio, non-voting)

Board Members
Sharon Jordan, Alabama
Marisa Ramos, California
David Kern, Chicago
Martin Luta, Delaware
Emma Spencer, Florida
William Lyons, Georgia
Randy Mayer, Iowa
Samuel Burgess, Louisiana
Colin Flynn, Maryland
Dawn Fukuda, Massachusetts
Kathryn Macomber, Michigan
Andrew Gans, New Mexico
Jacquelyn Clymore, North Carolina
Thomas Bertrand, Rhode Island
Tracey Packer, San Francisco
Ali Mansaray, South Carolina
Meredith Brantley, Tennessee

“It is my pleasure to welcome the 2021-2022 NASTAD Board of Directors,” said Stephen Lee, NASTAD Executive Director. “For the last 30 years, NASTAD has worked to lead initiatives to end the HIV and hepatitis epidemics. I am looking forward to working with the new Board of Directors to continue this work, while addressing systemic inequities and strengthening our public health infrastructure.”

###

About NASTAD
Founded in 1992, NASTAD is a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. Our singular mission is to end the intersecting epidemics of HIV, viral hepatitis, and related conditions. We do this work by strengthening governmental public health through advocacy, capacity building, and social justice.